hydroxyzine (TransDermal Technologies)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namehydroxyzine (TransDermal Technologies)
Drug Alias Namehydroxyzine TDS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesTransdermal Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransdermal Corp
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A